Navigation Links
Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
Date:7/27/2009

New York, NY The Lymphoma Research Foundation (LRF) is pleased to announce that the 2009 Millennium Pharmaceuticals, Inc./Lymphoma Research Foundation Clinical Investigator Career Development Award has been awarded to Kai Fu, MD, PhD, Associate Professor at the Nebraska Medical Center in Omaha, Nebraska.

Lymphoma, the most common type of blood cancer, is broadly categorized into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). According to a 2008 report from the World Health Organization, there are six types of HL and over 61 types of NHL; many of which are rare diseases.

A member of LRF's Mantle Cell Lymphoma Consortium (MCLC), Dr. Fu's work will focus on mantle cell lymphoma (MCL), an aggressive malignant B-cell form of non-Hodgkin lymphoma (NHL). Mantle cell lymphoma is a rare form of NHL accounting for 6 percent of all new diagnoses of NHL or approximately 3,000 new cases per year in the United States. Mantle cell usually affects men over 60 and is frequently diagnosed as a Stage IV disease, often present in lymph nodes above and below the diaphragm and in most cases involves the gastrointestinal tract and bone marrow.

MCL is characterized by over expression of the gene cyclin D1 due to a chromosomal translocation. A subset of MCL also expresses higher levels of a group of small RNA molecules, called miR-17~92. Dr. Fu and his co-workers have found that higher expression of miR-17~92 is directly correlated with poorer patient survival. These findings indicate that higher miR-17~92 expression induces abnormal activation of a pathway in tumor cells that leads to increased resistance to standard chemotherapy. Dr. Fu will conduct a pre-clinical study to determine whether suppression of miR-17~92 will improve the effect of chemotherapy. His study will thus provide a novel approach to treating MCL patients.

"Dr. Fu's elegant proposal explores a new avenue for understanding MCL and identifying potential therap
'/>"/>

Contact: Marion F. Swan
mswan@lymphoma.org
212-349-6435
Lymphoma Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments
2. Armed Forces Retirement Home Selects Millenniums Pharmacy Services
3. Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group
4. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
5. Industry Veteran Stephen Duvall Joins Millennium Management Team
6. Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group
7. Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool
8. Although the Health Care Market is Recession-Resistant, It Is Not Recession-Immune, According to Millennium Research Groups Medtech Economic Quarterly Publication
9. US Spinal Nonfusion Procedures Set to Increase Nearly Five Times From 2008 to 2013, According to Millennium Research Group
10. Healthcare Businesswomens Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company
11. Thrombectomy Device Market to Approach $300 Million by 2013, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Philadelphia, PA (PRWEB) May 22, 2015 According ... as a hub for drug related death, totaling almost 2,500 ... number, as reported by state officials, totals 2,489 deaths stemming ... numbers work out, Pennsylvania loses seven people every day to ... Philadelphia has been singled out as one of the most ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Gateway Building ... exterior renovations. The services the company specialize in include ... remodeling, basements, pool houses and much more. , ... by the owner of the company. It includes two ... The design was thought out to be used with ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
(Date:5/22/2015)... Raton, FL (PRWEB) May 22, 2015 ... which provides vascular, electrocardiogram (EKG), echocardiogram and NCV ... David Sempier, a highly respected All American National athlete, ... multi-sport athlete, I find the high level of testing ... both the athlete and their athletic trainers, this way ...
(Date:5/22/2015)... Ticket Down is a reputable source for authentic ... Conference Finals Tickets . All seating for the 2015 ... ticket listing. , For the first time in some ... the Eastern Conference. One of the original franchises in the ... downs over the years, but the excitement level for this ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... ,Raised Without Antibiotics, ... ... third,largest poultry producer, has joined the Truthful Labeling Coalition (TLC),an industry ... all 50 states and other leading poultry companies,including Foster Farms, Gold,n ...
... say , , MONDAY, Dec. 10 (HealthDay News) -- Scientists ... called BRCA1 can cause some breast cancers. , Basal-like ... of all breast cancers. BBCs generally have a poor ... associated with hereditary mutations in the BRCA1 gene, the ...
... Neuropsychopharmacology Annual Meeting will feature hundreds of new ... leading scientists. Presentations include innovative research on ... autism and addiction. , SELECTED PANELS INCLUDE:, , ... A series of studies elucidates evidence that there ...
... /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,a biopharmaceutical company ... therapies, today announced that the start of,Company,s ... murine monoclonal,antibody radiolabeled with Iodine-131 (I-131), is ... from a nuclear facility in Chalk River,Ontario. ...
... the mechanisms that modulate the response of ovarian cancer ... in the December issue of Cancer Cell, helps to ... class of drugs and may lead to improved treatment ... undergo extensive microtubule-driven restructuring as they proliferate. Taxanes, such ...
... Zender, a senior clinical postdoctoral fellow at Cold Spring ... for his seminal contributions in the field of cancer ... annual Cracking the Code with the Bear Research Symposium, ... Zender studies the genetics and biology of hepatocellular carcinoma, ...
Cached Medicine News:Health News:Truthful Labeling Coalition Welcomes Perdue Farms 2Health News:Truthful Labeling Coalition Welcomes Perdue Farms 3Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 2Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 3Health News:New studies on cancer and schizophrenia, depression and heart disease, trauma and autism 2Health News:Bradmer Medical Isotope Supply For Phase III Trial Secure 2Health News:Bradmer Medical Isotope Supply For Phase III Trial Secure 3Health News:Extracellular protein sensitizes ovarian cancer cells to chemotherapy 2Health News:CSHL scientist recognized for accelerating cancer gene research 2
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "North ... & Graft), by Application (Surgical Wound, & Ulcer), ... Forecast to 2019" report to their offering. ... wound care market is estimated to grow at ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ... Greg Watson , the company,s vice president of operations, ... company,s common stock, at a per share exercise price of ... stock option was granted pursuant to Cardica, Inc.,s Inducement Plan, ... May 2015 under Rule 5653(c)(4) of the Nasdaq Global Market ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
... when it comes to superior immobilization and cervical ... job., ,You already know that the most ... of the c-spine. But what you may not ... Medical's NECLOC ®: provides superior immobilization over the ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... The B3 Triplanar hip joint ... Flexion - extension, abduction - ... on our Boston Post-Op Hip ... our custom Hip Spicas in ...
... the most significant advance in walker design in years. ... where the weight bearing surfaces of the foot rest ... absorbed at the heel strike. The footbed in the ... for added comfort and stability. , ,No leg ...
Medicine Products: